HBMN.SW Stock — Price, Charts & Analysis

HBM Healthcare Investments AG (HBMN.SW) has a trailing P/E of 2.45x and a forward P/E of 15.00x. This places HBMN.SW in a lower earnings multiple territory based on the valuation data currently available on Worldtickers.

HBMN.SW trades with 2.45x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether HBMN.SW looks overvalued or undervalued.

HBMN.SW's P/E of 2.45x should be judged against Financial Services peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

HBMN.SW's trailing EPS is CHF 97.67 and forward EPS is CHF 15.97.

EPS, or earnings per share, shows how much profit HBM Healthcare Investments AG generated for each share. HBMN.SW's trailing EPS is CHF 97.67, and investors usually prefer EPS that is positive and growing over time.

HBM Healthcare Investments AG has a market cap of CHF 1.56B, making HBMN.SW a small-cap stock based on the current market value shown on Worldtickers.

HBMN.SW's latest stock price on Worldtickers is CHF 239.50. The latest move is -CHF 4.00 or -1.64%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

HBMN.SW's quote includes a latest price of CHF 239.50. The market open is CHF 243.50. Previous close is CHF 243.50. The intraday range is CHF 236.00 to CHF 245.00.

HBMN.SW is down in the latest quote, with a move of -CHF 4.00 or -1.64%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

HBMN.SW generated CHF 654.17M in trailing revenue.

Yes, HBMN.SW shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is CHF 650.22M.

Gross margin is 100.00%. Margins show how efficiently HBM Healthcare Investments AG turns revenue into profit.

HBM Healthcare Investments AG carries CHF 166.80M and holds CHF 8.29M in cash.

HBMN.SW holds CHF 8.29M on its balance sheet.

HBMN.SW's book value per share is CHF 306.20.

Yes, HBM Healthcare Investments AG pays a dividend of CHF 9.00 per share annually. The dividend yield is 370.00%. The payout ratio is 9.21%.

HBMN.SW's dividend yield is 370.00%. Its payout ratio is 9.21%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for HBMN.SW. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through HBM Healthcare Investments AG's investor relations materials.

HBMN.SW's five-year average dividend yield is 407.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 10.54% of HBMN.SW shares. Insiders hold 16.58% of shares. Ownership mix helps investors understand how much of HBM Healthcare Investments AG is held by professional investors and company insiders.

HBMN.SW has 6.53M shares outstanding. Float shares are 5M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for HBMN.SW, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for HBMN.SW is CHF 15.97. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

HBMN.SW's trailing EPS is CHF 97.67. Forward EPS is CHF 15.97. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

HBMN.SW is in the Financial Services sector. Its earnings multiple is 2.45x. Compare these figures with sector peers before deciding whether HBM Healthcare Investments AG is stronger or weaker than average.

HBMN.SW trades at CHF 239.50. The stock trades at 2.45x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of HBM Healthcare Investments AG's fundamentals.

HBMN.SW risks include company execution, valuation, competition in Financial Services, interest rates, and broad market volatility. Beta is 0.76, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

HBMN.SW should be compared with companies in Asset Management. Its earnings multiple is 2.45x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

HBM Healthcare Investments AG (HBMN.SW) operates in Financial Services, specifically Asset Management. HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger cor

HBMN.SW trades on Swiss. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

HBMN.SW stock is priced in CHF on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

HBM Healthcare Investments AG's official website listed on Worldtickers is www.hbmhealthcare.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

HBM Healthcare Investments AG is headquartered in Zug, Switzerland. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

HBMN.SW is in the Financial Services sector and the Asset Management industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

HBMN.SW has traded between CHF 169.40 and CHF 258.00 over the past 52 weeks. At CHF 239.50, it is 7.17% below the high and 41.38% above the low. The 52-week range helps gauge long-term price momentum.

HBMN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. Its 50-day moving average is CHF 245.29 and its 200-day moving average is CHF 222.18.

HBMN.SW's RSI is 32.72. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

HBMN.SW's latest RSI reading is 32.72, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for HBMN.SW is near CHF 242.00. Key resistance is near CHF 258.00. Breaks above resistance or below support can change the short-term technical setup.

HBMN.SW's nearest reported support level is CHF 242.00. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

HBMN.SW's nearest reported resistance level is CHF 258.00. A breakout above resistance can improve momentum, especially when volume confirms the move.

HBMN.SW trades about 3.88K shares daily on average. The latest displayed volume is 7.61K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

HBMN.SW's MACD is -1.38, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

HBMN.SW is between its 50-day and 200-day moving averages, which suggests a mixed trend setup. RSI is 32.72 (neutral). MACD is bearish. Nearest support is around CHF 242.00. Resistance is around CHF 258.00. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is CHF 249.45 (-3.99% from price). MA50 is CHF 245.29 (-2.36% from price). MA200 is CHF 222.18 (7.80% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. HBMN.SW's MA20 is CHF 249.45. MA50 is CHF 245.29. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

HBMN.SW's pivot is near CHF 245.17. Support is near CHF 242.00. Resistance is near CHF 258.00. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for HBMN.SW is near CHF 232.46. The next upper resistance zone is near CHF 247.50. These levels help define risk and possible follow-through zones after a breakout or breakdown.

HBMN.SW's Bollinger range is roughly CHF 243.43 to CHF 255.47. Band width is near 4.83%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

HBMN.SW's ATR-based typical daily range is about 1.88%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 7.61K shares. Average volume is about 3.88K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

HBMN.SW's all-time high shown on Worldtickers is CHF 367.00. Its all-time low is CHF 18.00. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

HBMN.SW has a beta of 0.76, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.